Back to results
US 11,845,761 B2Granted
Tricyclic pyridones and pyrimidones
AssigneeErasca, Inc.
InventorsJun Feng, Jean-Michel Vernier, Marcos Gonzalez-Lopez, Benjamin Jones, Nicholas A. Isley, Ping Chen
Life of this patent
Estimating the term…
Abstract
Compounds with KRAS G12C inhibitory active are disclosed and methods of using the same to treat a cancer comprising a K-Ras G12C mutation.
Claims30
A compound selected from:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.